One ecosystem. One global stage.
RGMBS 2026 is the flagship umbrella initiative for the Riyadh Global Medical Biotechnology Summit, positioning the Kingdom at the forefront of global biotech. At its heart sits the Life Sciences Innovation Forum (LSIF), the premier stage where startups, investors, and industry leaders connect, compete, and collaborate. Your application enters through Life Sciences Innovation Forum (LSIF), opening the door to the wider RGMBS ecosystem.
The Life Sciences Innovation Forum is a premier three-days platform developed in partnership with leading regional and international biotech investment funds. The forum brings together investors, innovators, researchers, and industry leaders to explore the next generation of breakthroughs shaping the future of life sciences in the Kingdom and beyond.
Held in Riyadh, Kingdom of Saudi Arabia, the Summit advances the wise leadership's commitment to positioning biotechnology as a strategic national priority. It aligns with the National Biotechnology Strategy, launched by His Royal Highness the Crown Prince in early 2024, to accelerate innovation, strengthen sustainability, and enhance the Kingdom's global competitiveness across high-value biotechnology domains and bio-based industries.
Key Dates
Built for founders — this competition is your gateway to investors, partners, and the Saudi life sciences ecosystem. Here is what you gain, and what we set out to achieve together.
Our shared objectives
Showcase breakthrough innovation
Highlight transformative technologies in biotechnology and healthcare on a world-class stage.
Connecting startups with capital and strategic partners
Bridge the gap between founders, investors, industry leaders, and strategic partners.
Accelerate commercialization
Support growth, market expansion, and the path from innovation to real-world impact.
Attract innovators to Saudi Arabia
Draw innovative companies to establish or expand operations in the Kingdom.
Strengthen the ecosystem
Build sustained cross-sector collaboration and investment across the life sciences landscape.
What you gain as a founder
Startups apply to one heat that best matches their technology platform. Each heat features dedicated pitching sessions, expert judges, and a pathway to the RGMBS 2026 finals.
AI & Bio Data
Artificial intelligence, machine learning, and computational biology solutions that accelerate drug discovery, diagnostics, and precision medicine through data-driven insights.
Vaccine Development & Bio-Manufacturing
Advanced vaccines, biologics, and scalable manufacturing platforms driving global immunisation and therapeutic delivery.
Cellular Therapy & Gene Editing
Cell-based therapies, CRISPR and gene-editing platforms, and regenerative medicine innovations transforming treatment of genetic and chronic diseases.
Bioengineering & Synthetic Biology
Engineered biological systems, synthetic organisms, and bio-based materials driving sustainable industrial and healthcare applications.
Diagnostics & Drug Discovery
Novel diagnostic tools, biomarker platforms, and drug discovery technologies that improve early detection and accelerate therapeutic development.
Ready to apply
Applications are assessed by a panel of scientific advisors and investment professionals across six core dimensions:
Application
Register, complete your profile, and submit your pitch deck for blind review
Selection
Expert panel evaluates submissions and shortlists top candidates
Heats
Shortlisted startups pitch in their chosen heat — winners advance to finals
Finals
Finalists present live to investors and industry leaders at LSIF
Winner
Announced at RGMBS 2026 with regional recognition and investment pathways
- Innovation
- Scientific validity
- Commercial potential
- Market relevance
- Team capability
- Strategic fit with Saudi Arabia's National Biotechnology Strategy
LSIF Startup Competition · RGMBS 2026
Questions about your application, the competition timeline, or event logistics? Our team is here to help you every step of the way.
Partners & Sponsors
Key Strategic Partner
Hosted By
Strategic Partner
